SCE Mrv0541 02241214092D 18 20 0 0 0 0 999 V2000 -1.2664 1.8755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4818 1.6206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.4818 0.7956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2664 0.5407 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.7513 1.2081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2327 2.0331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9472 1.6206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9472 0.7956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.2327 0.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2327 -0.4419 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.9472 -0.8544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9472 -1.6794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6617 -2.0919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6617 -2.9169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9472 -3.3294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.2327 -2.9169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2327 -2.0919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5213 2.6602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 18 1 0 0 0 0 2 6 1 0 0 0 0 3 9 1 0 0 0 0 3 2 1 0 0 0 0 4 5 1 0 0 0 0 4 3 2 0 0 0 0 5 1 2 0 0 0 0 7 6 2 0 0 0 0 8 7 1 0 0 0 0 9 8 2 0 0 0 0 10 11 1 0 0 0 0 10 9 1 0 0 0 0 12 13 1 0 0 0 0 12 11 1 0 0 0 0 14 13 2 0 0 0 0 15 14 1 0 0 0 0 16 15 2 0 0 0 0 16 17 1 0 0 0 0 17 12 2 0 0 0 0 M END > DB08533 > drugbank > CC1=CN=C2N1C=CN=C2NCC1=CC=NC=C1 > InChI=1S/C13H13N5/c1-10-8-17-13-12(15-6-7-18(10)13)16-9-11-2-4-14-5-3-11/h2-8H,9H2,1H3,(H,15,16) > LXRVAGIYXNQOKP-UHFFFAOYSA-N > C13H13N5 > 239.2758 > 239.117095441 > 4 > 31 > 0.011928202981666093 > 25.845229763441637 > 1 > 1 > 0 > 1 > 3-methyl-N-[(pyridin-4-yl)methyl]imidazo[1,2-a]pyrazin-8-amine > 1.43 > 0.3154746680000002 > -3.74 > 0 > 0 > 3 > 0 > 16.05978885539339 > 5.090285162553741 > 55.11 > 71.8922 > 3 > 1 > 4.32e-02 g/l > tetrahydrofolic acid > 0 > DB08533 > experimental > 3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine $$$$